{
    "nct_id": "NCT05037123",
    "official_title": "Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain",
    "inclusion_criteria": "* Woman 18 years of age or older\n* Undergoing elective breast surgery for oncologic indication as follows: unilateral or bilateral mastectomy, prophylacticmastectomy, +/- lymph node dissection, +/- immediate or delayed reconstruction.\n* No distant metastases\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* History of cognitive impairment or clinical signs of altered mental status (AMS) that may interfere with adherence to study procedures and/or participant safety. Clinical signs of AMS may include but are not limited to: confusion, amnesia, disorientation, fluctuating levels of alertness, etc.\n* Past ketamine or phencyclidine misuse or abuse\n* Schizophrenia or history of psychosis\n* History of post-traumatic stress disorder\n* Known sensitivity or allergy to ketamine\n* Liver or renal insufficiency\n* History of uncontrolled hypertension, chest pain, cardiac arrhythmia, stroke, head trauma, intracranial mass or hemorrhage, glaucoma, porphyria, uncontrolled thyroid disease, or other contraindication to ketamine\n* Lamotrigine, alfentanil, physostigmine, or 4-aminopyridine use\n* Currently Pregnant\n* Body mass index (BMI) equal to or greater than 41\n* Non-English or non-Spanish speaker\n* Currently participating in another pain interventional trial\n* Unwilling to comply with all study procedures and be available for the duration of the study\n* Patient is American Society of Anesthesiologists (ASA) physical status 4, 5, or 6\n* Patient has started or undergone hormone therapy for gender transition into male.\n* Patient scheduled for any bilateral (or greater) flap reconstruction",
    "miscellaneous_criteria": ""
}